Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway

• Главные авторы: Jiarong Wang (Автор), Wei Jiang (Автор), Jiao Xin (Автор), Weiju Xue (Автор), Congjian Shi (Автор), Jiagen Wen (Автор), Yan Huang (Автор), Chengmu Hu (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is an independent risk factor for acute liver injury caused by overuse of acetaminophen (APAP). Caveolin-1 (CAV1), a regulator of hepatic energy metabolism and oxidative stress, was found to have a protective effect against NAFLD in our previous study. Howev...